Avoro Capital Advisors LLC - 30 Jun 2025 SCHEDULE 13G Report for MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share (MLTX)

Filing Manager: Avoro Capital Advisors LLC
Reporting Manager: Avoro Capital Advisors LLC
Security: MoonLake Immunotherapeutics Class A Ordinary Shares, par value $0.0001 per share
Symbol: MLTX
Shares outstanding: 63,846,154 shares
Disclosed Ownership: 4,150,000 shares
Ownership: 6.5%
Form type: SCHEDULE 13G
Filing time: 14 Aug 2025, 06:57:23 UTC
Date of event: 30 Jun 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Avoro Capital Advisors LLC	6.5%	4,150,000	4,150,000	0	/s/ Scott Epstein	Scott Epstein, Chief Financial Officer & Chief Compliance Officer
Behzad Aghazadeh	6.5%	4,150,000	4,150,000	0	/s/ Behzad Aghazadeh	Behzad Aghazadeh, Individually